Disclosure under Regulation 30 of SEBI (LODR) regarding appointmrent of M/S VRSK & Associates as Statutory Auditors of the Company .
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Johnson Pharmacare Ltd has appointed M/S VRSK & Associates (FRN: 011199N) as its new Statutory Auditor with effect from 13 February 2026. The appointment was made on the recommendation of the Audit Committee and the auditor will hold office until the conclusion of the next Annual General Meeting. Shareholders' approval will be sought at a general meeting to be convened within three months of the Board's recommendation. The firm is based in New Delhi, and the filing was signed by Additional Director Umesh Kumar. There is no mention of the previous auditor resigning mid-term in this disclosure.
This is a routine auditor appointment disclosure and is unlikely to have any material impact on the stock price. The change in auditor will be confirmed in the upcoming general meeting, and investors may want to verify the continuity of audit oversight during the transition.